Document and Entity Information
Document and Entity Information | Feb. 27, 2023 |
Cover [Abstract] | |
Entity Registrant Name | IMPEL PHARMACEUTICALS INC |
Amendment Flag | false |
Entity Central Index Key | 0001445499 |
Document Type | 8-K |
Document Period End Date | Feb. 27, 2023 |
Entity Incorporation State Country Code | DE |
Entity File Number | 001-40353 |
Entity Tax Identification Number | 26-3058238 |
Entity Address, Address Line One | 201 ELLIOTT AVE. W |
Entity Address, Address Line Two | SUITE 260 |
Entity Address, City or Town | Seattle |
Entity Address, State or Province | WA |
Entity Address, Postal Zip Code | 98119 |
City Area Code | 206 |
Local Phone Number | 568-1466 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Security 12b Title | Common Stock, $0.001 Par Value Per Share |
Trading Symbol | IMPL |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |